Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2005
11/03/2005WO2005001420A3 Method and apparatus for sensing hydrogen gas
11/03/2005WO2004113556A3 Assay and kits for detecting protein binding
11/03/2005WO2004108070A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers
11/03/2005WO2004093646A3 Prognosis, diagnosis and treatment of bone marrow derived stem cell associated cancer
11/03/2005WO2004080285A3 Amyloid plaque as a target for therapeutics that function by blocking or disrupting chitin synthesis or activity
11/03/2005WO2004072614A3 Method and apparatus for detecting an analyte
11/03/2005WO2004061407A3 Glycopeptide identification and analysis
11/03/2005WO2004057016A3 METHODS OF CAPTURING, DETECTING AND QUANTIFYING RNA:DNA HYBRIDS AND A MODIFIED RNase H USEFUL THEREIN
11/03/2005WO2004018647A3 Methods and compositions for categorizing patients
11/03/2005WO2003000842A3 Novel proteins and nucleic acids encoding same
11/03/2005US20050246794 Functional and hyperfunctional siRNA
11/03/2005US20050246106 Methods and systems for identifying genes, splice variants, and transcripts using an evidence mapping approach
11/03/2005US20050246105 Interpolated image response
11/03/2005US20050245836 Nanoelectronic capnometer adapter
11/03/2005US20050245835 Breath test
11/03/2005US20050245798 Device and system for humor component detection
11/03/2005US20050245730 Wound healing agents; anticancer agents; cardiovascular disorders; immunostimulants
11/03/2005US20050245728 Novel purified polypeptides from Pseudomonas aeruginosa
11/03/2005US20050245726 Detecting the phosphorylation activity of protein kinases using a substrate compound with hydrophobic moieties that integrate the compound into a micelle, non-proteinaceous fluorescent moieties (fluorescent dyes), and an enzyme recognition moiety
11/03/2005US20050245705 Ionic polymers and polymer-comprising substrates
11/03/2005US20050245564 Methods and compositions related to IRM compounds and toll-like receptor pathways
11/03/2005US20050245486 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits
11/03/2005US20050245481 Method of producing teicoplanin
11/03/2005US20050245475 Functional and hyperfunctional siRNA directed against Bcl-2
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050245453 Peptides derived from cadherin and methods of use thereof
11/03/2005US20050245449 Methods for modifying cell motility using factor VIIa antagonist
11/03/2005US20050244987 Detection device, detection apparatus, and detection kit employing the device and reagent
11/03/2005US20050244986 Assays
11/03/2005US20050244985 Chromatographic Assay Device and Methods
11/03/2005US20050244983 Method for measuring antioxidant status
11/03/2005US20050244981 automatically determining whether a sample liquid to be tested in an optical measuring instrument is a test sample or a control sample; using IR dye
11/03/2005US20050244978 Substance detection system
11/03/2005US20050244977 Adaptive metal films for detection of biomolecules
11/03/2005US20050244976 Methods for detecting anionic and non-anionic compositions using carbocyanine dyes
11/03/2005US20050244975 Method for monitoring a polymerization in a three-dimensional sample
11/03/2005US20050244974 High throughput property testing of olefin copolymers using rheological determinations
11/03/2005US20050244973 Biological patterns for diagnosis and treatment of cancer
11/03/2005US20050244970 Stem cell libraries
11/03/2005US20050244953 Techniques for controlling the optical properties of assay devices
11/03/2005US20050244952 electroluminescent illumination source provides electromagnetic radiation, which is capable of causing the production of a detection signal that correlates to the presence or quantity of the analyte; provides diffused light; inexpensive, easy to use, and accurate
11/03/2005US20050244943 Cell concentration and pathogen recovery
11/03/2005US20050244921 Fluorescent protein variants and methods for making same
11/03/2005US20050244918 Methods for detecting bacterial pathogens
11/03/2005US20050244916 Methods for predicting protein activity based on identification of multidimensional signatures
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244914 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
11/03/2005US20050244911 Methods and reagents for treating autoimmune disorders
11/03/2005US20050244910 Methods for determining glycemic responses of foods
11/03/2005US20050244907 Methods, compositions, and kits for analysis of enzyme activity in cells
11/03/2005US20050244906 Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and process for producing the same
11/03/2005US20050244905 Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation
11/03/2005US20050244904 Diagnostics based on signal peptide detection
11/03/2005US20050244903 Diagnostic and examination method for eating disorder
11/03/2005US20050244902 Methods for determining levels of human b-type natriuretic peptide precursors
11/03/2005US20050244900 Glycine N-methyltransferase monoclonal antibodies and methods of use therefor
11/03/2005US20050244899 Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
11/03/2005US20050244898 Large-area two-dimensional non-adhesive cell arrays for sensing and cell-sorting applications
11/03/2005US20050244897 Endothelial cells as diagnostic instrument in cardiovascular diseases
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244895 Diagnosis of demyelinating or spongiform disease
11/03/2005US20050244894 Modulators of paraptosis and related methods
11/03/2005US20050244893 Novel method for determination of plasminogen activator inhibitor
11/03/2005US20050244892 Resistin as a marker and therapeutic target for cardiovascular disease
11/03/2005US20050244891 Ligand-containing micelles and uses thereof
11/03/2005US20050244890 Biomarkers for Alzheimer's disease
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244887 Nucleic acid amplification reaction station for disposable test devices
11/03/2005US20050244883 Method and computer software product for genomic alignment and assessment of the transcriptome
11/03/2005US20050244880 Cellular arrays and methods of detecting and using genetic disorder markers
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244875 Sequencing preferential nucleotide sequences; obtain nucleotide sequences, insert preferential heavy elements into compound, insert into microscope, monitor base preferential labels, determine nucleotide sequence
11/03/2005US20050244873 Detecting method, detection device and detection kit
11/03/2005US20050244871 Polynucleotide probe having enhanced binding specificity, microarray having the probe immobilized thereon, and method of designing the probe
11/03/2005US20050244868 Ten-M3 polypeptides and polynucleotides and their methods of use
11/03/2005US20050244866 Methods for reducing the range in concentrations of analyte species in a sample
11/03/2005US20050244865 Molecular lithography with DNA nanostructures
11/03/2005US20050244864 High throughput screening of probes; measurement of levels of unbound free fatty acids; use in drug screening or to determine the individual's risk for disease such as stroke, cardiac disease and cancer
11/03/2005US20050244863 Molecular arrays and single molecule detection
11/03/2005US20050244859 Cell based assay
11/03/2005US20050244856 Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
11/03/2005US20050244854 Novel method for the identification of clones conferring a desired biological property from an expression library
11/03/2005US20050244853 Determining relative expression for probe groups in probe arrays
11/03/2005US20050244852 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/03/2005US20050244850 Assembly of arrays on chips segmented from wafers
11/03/2005US20050244848 Mass spectrometric analysis of biopolymers
11/03/2005US20050244844 serine/threonine phosphatases (PP1); immobilization, screening
11/03/2005US20050244843 Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
11/03/2005US20050244841 Computer-directed assembly of a polynucleotide encoding a target polypeptide
11/03/2005US20050244839 Granulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)
11/03/2005US20050244833 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/03/2005US20050244832 Class II cytokine receptor-7
11/03/2005US20050244829 Method of screening insulin resistance inproving drug
11/03/2005US20050244828 Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244824 Method of assaying target nucleic acid and kit therefor
11/03/2005US20050244823 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2005US20050244822 Method of monitoring gene expression
11/03/2005US20050244821 Method of identification and quantification of biological molecules and apparatus therefore
11/03/2005US20050244820 Detecting molecular binding by monitoring feedback controlled cantilever deflections